Sulfasalazine clinical trials
Also written Azulfidine.
Its developmentBy Bristol-Myers Squibb and Pfizer, step by step4 company-led studies, furthest phase 4: when each phase was reached, its deals, target and what is ahead.How each study uses Sulfasalazine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Sulfasalazine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 20 Jun 1950 · AZULFIDINE EN-TABS · NDA 007073 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
36 studies that test it; most in 2023 (5)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 3 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 29
Brigham and Women's Hospital (2) · University of Nebraska (2) · University of Alabama at Birmingham (2) · Cairo University (1) · University of Arizona (1) · Galapagos NV (1) · University of Illinois at Chicago (1) · Haukeland University Hospital (1)
Often tested with
Tested in the same studies.
Leflunomide (9) · Hydroxychloroquine (8) · Methotrexate (8) · Etanercept (8) · Adalimumab (5) · Certolizumab Pegol (4) · Infliximab (4) · Golimumab (3)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Sulfasalazine.
- Dec 2026Study of ECC4703 With Sulfasalazine and PitavastatinPhase 1 · Eccogene
Studies
Open first, then newest update. How each study uses Sulfasalazine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 36
- Study of ECC4703 With Sulfasalazine and PitavastatinRecruitingPhase 1EccogeneNCT07726368Written as SulfasalazineHow we know
- The Effect of Sulfasalazine on CRH Levels in Pregnant WomenRecruitingPhase 2Rutgers, The State University of New JerseyNCT05703425Written as SulfasalazineHow we know
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingPhase 2NYU Langone HealthNCT07138898Written as SulfasalazineHow we know
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of ResponseRecruitingPhase 3University of NebraskaNCT03414502Written as SulfasalazineHow we know
- Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line TreatmentRecruitingPhase 1/2Assistance Publique - Hôpitaux de ParisNCT05580861Written as SulfasalazineHow we know
- Glutamate Inhibitors in GlioblastomaRecruitingPhase 1/2University of ZurichNCT05664464Written as SulfasalazineHow we know
- A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus ErythematosusNot yet recruitingPhase 2Qiong FuNCT06360068Written as Sulfasalazine TabletsHow we know
- Sulfasalazine in Patients With Metastatic Colorectal CancerRecruitingPhase 3Tanta UniversityNCT06134388Written as SulfasalazineHow we know
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic ArthritisRecruitingPhase 3University of Erlangen-Nürnberg Medical SchoolNCT04610476Written as SulfasalazineHow we know
- Sulfasalazine for the Treatment of Primary Sclerosing CholangitisCompletedPhase 2Brigham and Women's HospitalNCT03561584Written as SulfasalazineHow we know
- Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer PatientsCompletedPhase 2University of ArizonaNCT03847311Written as SulfasalazineHow we know
- Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy SubjectsCompletedPhase 1Galapagos NVNCT04720183Written as SulfasalazineHow we know
- Topical Sulfasalazine and Oral Lichen PlanusActive, not recruitingPhase 3Cairo UniversityNCT06060301Written as sulfasalazine 500 MGHow we know
- IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIACompletedPhase 4University of Illinois at ChicagoNCT02451748Written as SulfasalazineHow we know
- Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid ArthritisCompletedPhase 3University of NebraskaNCT00579878Written as Methotrexate-Sulfasalazine-HydroxychloroquineHow we know
- Sulfasalazine and Stereotactic Radiosurgery for Recurrent GlioblastomaCompletedPhase 1Haukeland University HospitalNCT04205357Written as SulfasalazineHow we know
- A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of SulfasalazineCompletedPhase 1Bristol-Myers SquibbNCT05445440Written as SulfasalazineHow we know
- Treatments Against RA and Effect on FDG-PET/CTCompletedPhase 4Brigham and Women's HospitalNCT02374021Written as SulfasalazineHow we know
- A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677CompletedPhase 1CelgeneNCT04268394Written as SulfasalazineHow we know
- Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate MonotherapyTerminatedPhase 3Jawaharlal Institute of Postgraduate Medical Education & ResearchNCT02930343Written as SulfasalazineHow we know
See all 36 studies that test Sulfasalazine →
Given beside what is tested · 14 — Sulfasalazine is usual care or a partner of the new treatment
- Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED TrialCompletedPhase 4University of OxfordNCT03739853Written as SulfasalazineHow we know
- Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid ArthritisCompletedPhase 4SanofiNCT03449758Written as SulfasalazineHow we know
- Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDsStatus unknownPhase 4Nanfang Hospital, Southern Medical UniversityNCT04077957Written as SulfasalazineHow we know
- Very Early Versus Delayed Etanercept in Patients With RACompletedPhase 4University of LeedsNCT02433184Written as SulfasalazineHow we know
- A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid ArthritisCompletedPhase 3Hoffmann-La RocheNCT01941095Written as SulfasalazineHow we know
- A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)CompletedPhase 3SanofiNCT02373202Written as SulfasalazineHow we know
- To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)CompletedPhase 3SanofiNCT01709578Written as sulfasalazineHow we know
- To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)CompletedPhase 3SanofiNCT01768572Written as sulfasalazineHow we know
- To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid ArthritisCompletedPhase 3SanofiNCT02057250Written as SulfasalazineHow we know
- Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration MediumsCompletedPhase 1University Medicine GreifswaldNCT03012763Written as SulfasalazineHow we know
- Effects of 500 mg Immediate Release and Extended Release Methylnaltrexone on Loperamide-induced Delay of the Oro-cecal and Whole-gut Transit Time in Healthy SubjectsCompletedPhase 1University Medicine GreifswaldNCT01596777Written as SulfasalazineHow we know
- Dose Reduction of Etanercept in Patients With Ankylosing SpondylitisStatus unknownPhase 4Zhixiang HuangNCT02638896Written as SulfasalazineHow we know
- An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy SubjectsCompletedPhase 1Tesaro, Inc.NCT02434861Written as SulfasalazineHow we know
- Effects of Methylnaltrexone in Comparison to Naloxone on Loperamide-induced Delay of the Oro-cecal, Whole-gut and Colon Transit Time.CompletedPhase 1University Medicine GreifswaldNCT01596764Written as SulfasalazineHow we know
As the comparator · 4 — what is tested is compared with Sulfasalazine
- Methotrexate, Blood Pressure and Arterial Function in Rheumatoid ArthritisCompletedPhase 4Flinders UniversityNCT03254589Written as SulfasalazineHow we know
- Psoriatic Oligoarthritis Intervention With Symptomatic thErapyCompletedPhase 4University of OxfordNCT03797872Written as SulfasalazineHow we know
- Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell StratificationStatus unknownPhase 4University of LeedsNCT03813771Written as SulfasalazineHow we know
- Study Evaluating Etanercept and Sulphasalazine in Ankylosing SpondylitisCompletedPhase 4Wyeth is now a wholly owned subsidiary of PfizerNCT00247962Written as sulphasalazine (SSZ)How we know
Codes
What other systems call Sulfasalazine · ClinicalTrials.gg INT008175
- MeSH (NLM) D012460SulfasalazineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 3XC8GUZ6CBSULFASALAZINEConfirmed FDA, NLM, Wikidata
- RxNorm 9524Confirmed FDA, Wikidata
- Wikidata Q420035sulfasalazineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29469SulfasalazineOne source FDA
- DrugBank DB00795One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D012460 | Sulfasalazine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 3XC8GUZ6CB | SULFASALAZINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 9524 | — | Confirmed FDA, Wikidata |
| Wikidata | Q420035 | sulfasalazine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29469 | Sulfasalazine | One source FDA |
| DrugBank | DB00795 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.